Massih Ningarhari

1.5k total citations · 1 hit paper
22 papers, 801 citations indexed

About

Massih Ningarhari is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Massih Ningarhari has authored 22 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 10 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Massih Ningarhari's work include Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Massih Ningarhari is often cited by papers focused on Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Massih Ningarhari collaborates with scholars based in France, United States and Belgium. Massih Ningarhari's co-authors include Jean‐Charles Nault, Jessica Zucman‐Rossi, Sandra Rebouissou, Alexandre Louvet, Guillaume Lassailly, Viviane Gnemmi, Philippe Mathurin, Sébastien Dharancy, Hélène Verkindt and Violeta Raverdy and has published in prestigious journals such as Gastroenterology, The American Journal of Human Genetics and Journal of Hepatology.

In The Last Decade

Massih Ningarhari

18 papers receiving 790 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis

2020 382 citations Guillaume Lassailly, Robert Caïazzo et al. Gastroenterology profile →

Peers

Massih Ningarhari

EPIDE

HEPAT

SURGE

EDM

Rie Irie Japan

Tejasav S. Sehrawat United States

Andrea Marengo Italy

Tetsuya Yasunaka Japan

Dina Halegoua‐DeMarzio United States

Narcissus Teoh Australia

Soichiro Saikawa Japan

Kengo Kawai Japan

Kazunori Ishige Japan

Yoshihiro Kanbara Japan

Rie Irie Japan

Massih Ningarhari

390 ×0.8

EPIDE

285 ×1.3

HEPAT

229 ×1.1

SURGE

186 ×0.9

119 ×0.7

EDM

Citations per year, relative to Massih Ningarhari Massih Ningarhari (= 1×) peers Rie Irie

Countries citing papers authored by Massih Ningarhari

Since Specialization

Citations

This map shows the geographic impact of Massih Ningarhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massih Ningarhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massih Ningarhari more than expected).

Fields of papers citing papers by Massih Ningarhari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massih Ningarhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massih Ningarhari. The network helps show where Massih Ningarhari may publish in the future.

Co-authorship network of co-authors of Massih Ningarhari

This figure shows the co-authorship network connecting the top 25 collaborators of Massih Ningarhari. A scholar is included among the top collaborators of Massih Ningarhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massih Ningarhari. Massih Ningarhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ningarhari, Massih, Guillaume Lassailly, Sébastien Dharancy, Christophe Moreno, & Eric Trépo. (2025). Recurrence of Hepatocellular Carcinoma After Liver Transplantation: The Blind Spot of HCC Management. United European Gastroenterology Journal. 13(7). 1069–1076.

Bureau, Côme, Pauline Wils, E. Merlen, et al.. (2025). Life-threatening immune-related adverse events in the intensive care unit: a narrative review. Intensive Care Medicine. 51(12). 2289–2304.

Lassailly, Guillaume, Robert Caïazzo, Mikaël Chetboun, et al.. (2024). Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study. Clinical Gastroenterology and Hepatology. 23(9). 1567–1576.e9. 2 indexed citations

Ningarhari, Massih, Nicolas Bertrand, Christophe Desauw, et al.. (2023). Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case–control study. Liver International. 44(3). 682–690.

Ningarhari, Massih, Guillaume Lassailly, Sébastien Dharancy, et al.. (2022). Liver Transplantation in Alcohol-related Liver Disease and Alcohol-related Hepatitis. Journal of Clinical and Experimental Hepatology. 13(1). 127–138. 7 indexed citations

Ningarhari, Massih, Elise Lemaître, Emmanuel Boleslawski, et al.. (2022). Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study. United European Gastroenterology Journal. 10(4). 396–408. 9 indexed citations

Ningarhari, Massih, Abbas Mourad, Guillaume Lassailly, et al.. (2022). Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach. Hepatology Communications. 6(10). 2964–2974. 1 indexed citations

Houy, Alexandre, Olivier Ganier, Florent Dingli, et al.. (2022). Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor. The American Journal of Human Genetics. 109(12). 2196–2209. 3 indexed citations

Lassailly, Guillaume, Massih Ningarhari, V. Canva, et al.. (2022). Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation. Transplant International. 35. 10569–10569. 6 indexed citations

10.

Ningarhari, Massih, Elise Lemaître, Guillaume Lassailly, et al.. (2022). Lung Infection Affects Access to Treatment and Short-Term Outcome in Patients With Severe Alcohol-Related Hepatitis Treated With Corticosteroids. The American Journal of Gastroenterology. 117(7). 1097–1105. 4 indexed citations

11.

Louvet, Alexandre, Emmanuel Boleslawski, Viviane Gnemmi, et al.. (2021). Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis. Journal of Hepatology. 75(4). 912–923. 56 indexed citations

12.

Facchinetti, Fabio, Ratislav Bahleda, Loïc Verlingue, et al.. (2021). 34MO Outcomes according to FGFR alteration types in patients with a solid tumour treated by a pan-FGRF tyrosine kinase inhibitor in phase I/II trials. Annals of Oncology. 32. S14–S15. 1 indexed citations

13.

Procureur, Adrien, Loïc Verlingue, Francesco Facchinetti, et al.. (2021). 711P Outcomes according to genomic characteristics of patients with metastatic urothelial carcinoma in phase I/II trials. Annals of Oncology. 32. S718–S719. 1 indexed citations

14.

Lassailly, Guillaume, Robert Caïazzo, Viviane Gnemmi, et al.. (2020). Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis. Gastroenterology. 159(4). 1290–1301.e5. 382 indexed citations breakdown →

15.

Artru, Florent, François Maggiotto, Guillaume Lassailly, et al.. (2020). IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis. Journal of Hepatology. 72(6). 1052–1061. 45 indexed citations

16.

Lassailly, Guillaume, Mehdi El Amrani, Flavien Vincent, et al.. (2020). Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients. American Journal of Transplantation. 20(9). 2567–2570. 4 indexed citations

17.

Lassailly, Guillaume, Jérôme Dumortier, Franck Saint‐Marcoux, et al.. (2020). Real life experience of mycophenolate mofetil monotherapy in liver transplant patients. Clinics and Research in Hepatology and Gastroenterology. 45(1). 101451–101451. 3 indexed citations

18.

Ningarhari, Massih, Stefano Caruso, Théo Z. Hirsch, et al.. (2020). Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target. Journal of Hepatology. 74(5). 1155–1166. 73 indexed citations

19.

Lassailly, Guillaume, Massih Ningarhari, Rodolphe Carpentier, et al.. (2019). Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules. Journal of Hepatology. 70(6). 1159–1169. 22 indexed citations

20.

Nault, Jean‐Charles, Massih Ningarhari, Sandra Rebouissou, & Jessica Zucman‐Rossi. (2019). The role of telomeres and telomerase in cirrhosis and liver cancer. Nature Reviews Gastroenterology & Hepatology. 16(9). 544–558. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact